Retinal periphlebitis resembling frosted branch angiitis with nonperfused central retinal vein occlusion

Eur J Ophthalmol. Nov-Dec 2003;13(9-10):807-12. doi: 10.1177/1120672103013009-1015.

Abstract

Purpose: To report the unusual association between severe retinal periphlebitis resembling frosted branch angiitis and nonperfused central retinal vein occlusion (CRVO).

Methods: Observational case reports.

Results: Patient 1 was a 28-year-old man who presented with extensive sheathing involving all retinal veins in one eye followed by nonperfused CRVO. Twenty-seven months after initial presentation, he developed perfused CRVO in the other eye followed by periphlebitis that progressed into nonperfused CRVO. Patient 2 was a 47-year-old man who presented with unilateral severe retinal periphlebitis associated with nonperfused CRVO. Despite systemic administration of corticosteroid therapy, rubeosis iridis developed in both patients and neovascular glaucoma developed in Patient 1 despite full panretinal photocoagulation. Extensive systemic workup and coagulation studies were unremarkable except for the presence of antiphospholipid antibodies in both patients and elevated plasma homocysteine level in Patient 2.

Conclusions: Severe retinal periphlebitis complicated by nonperfused CRVO is associated with poor visual outcome despite appropriate medical and surgical treatment.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Fluorescein Angiography
  • Glaucoma, Neovascular / diagnosis
  • Glaucoma, Neovascular / drug therapy
  • Glaucoma, Neovascular / etiology
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Phlebitis / complications*
  • Phlebitis / diagnosis
  • Phlebitis / therapy
  • Retinal Diseases / complications*
  • Retinal Diseases / diagnosis
  • Retinal Diseases / therapy
  • Retinal Vasculitis / diagnosis
  • Retinal Vein / pathology*
  • Retinal Vein Occlusion / diagnosis
  • Retinal Vein Occlusion / etiology*
  • Retinal Vein Occlusion / therapy
  • Treatment Outcome
  • Visual Acuity

Substances

  • Glucocorticoids